Thiazolidinediones

From WikiMD.org
Jump to navigation Jump to search

Thiazolidinediones

Thiazolidinediones (pronounced: thy-uh-zoh-lih-deen-dye-ohns), also known as glitazones, are a class of medications used in the treatment of Type 2 diabetes. They are part of the antidiabetic drugs category and work by reducing insulin resistance in the body.

Etymology

The term "Thiazolidinediones" is derived from the chemical structure of these drugs, which includes a thiazolidine ring and two ketone groups. The suffix "-dione" is used in organic chemistry to denote the presence of two ketone groups.

Usage

Thiazolidinediones are used primarily in the treatment of Type 2 diabetes, a condition characterized by high blood sugar levels due to the body's inability to properly use insulin. They work by binding to the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ, in fat cells. This action makes the cells more responsive to insulin, thereby reducing blood sugar levels.

Related Terms

Side Effects

Like all medications, thiazolidinediones can cause side effects. These may include weight gain, anemia, and increased risk of heart failure. It is important to discuss these potential risks with a healthcare provider before starting treatment with a thiazolidinedione.

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski